Patients were randomly allocated ( 1:1 ) by a computer-generated randomisation schedule to receive one of the following nine treatments : a once a day dose of 1 mg , 25 mg , 5 mg , or 10 mg TA-8995 or matching placebo ; 10 mg TA-8995 plus 20 mg atorvastatin ; 10 mg TA-8995 plus 10 mg rosuvastatin or 20 mg atorvastatin or 10 mg rosuvastatin alone .